believ altria deliv averag ep growth driven price
cost save buyback equiti incom believ near-term downsid risk like
limit near-term catalyst includ moder volum declin acceler iqo
momentum though increment dollar profit sustain level
price altria recent rais cigarett price per pack year-ago price
hike could indic manag price trajectori like return
updat estim lower expect equiti incom ab inbev trim
ep equiti incom estim base
abi report profit report lag forecast use updat
consensu estim trim ep ep
maintain target reiter ow
cigarett volum declin price may prove manag continu believ
cigarett categori volum declin could improv help allow
moder price increas drive net revenu gain altria rais list price
cigarett per pack effect februari less per
pack increas manufactur took april look like manag
price trajectori could like return potenti eas investor concern price
increas go forward could prove aggress cigarett categori declin
continu moder also could help price outlook latest
week end per iri categori volum declin better declin
week similar chart insid
valuat dividend yield attract consid valuat compel current
level ep even trim lower expect equiti incom
dividend yield consid dividend risk
believ tobacco packag food name like perform well even event
coronaviru disrupt travel discretionari spend etc
time catalyst unknown downsid risk look limit expect
moder cigarett categori declin vs believ could help lift sentiment
toward altria share also believ continu growth iqo launch
potenti sentiment catalyst though expect net contributor earn
reach greater scale us like earliest iqo sale
still small us continu grow chart insid fda approv mrtp
could boost growth time potenti upsid catalyst unclear believ
moder cigarett categori declin promis downsid risk also look limit
unfavor regul disrupt excis tax hike gain illicit trade risk profit
altria commerci tobacco product us brand like marlboro skoal
price target ep
current multipl
ep expect altria deliv three-
year averag sale growth averag
revenu exclud excis tax
piper sandler seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
declin continu
us cigarett categori volum continu moder averag
latest week end februari exhibit improv steadi sinc
lower volum declin also like allow altria take manag price hike consum
us cigarett categori volum declin period approxim match quarter
iqo us sale
small move
right direct
note use week measur data februari period use week data iri piper sandler co
iqo sale still small us sequenti growth measur retail sale
encourag exhibit expect measur retail sale small initi
launch consum get initi sleev heatstick promot bundl devic
iqo store howev believ steadi improv posit indic potenti
traction consum fda approv iqo modifi risk tobacco product applic
mrtp could signific catalyst littl visibl time process
know public comment period new amend close late februari
iqo sale us measur retail channel
page
excis tax rev
good
cog percent sale
net incom attrib noncontrol int
net incom attrib altria
earn attribut share-bas award
current disclosur inform compani found www pipersandl com/researchdisclosur
